Veno-Venous Extracorporeal Lung Support as a Bridge to or Through Lung Volume Reduction Surgery in Patients with Severe Hypercapnia.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 3 8 2020
pubmed: 3 8 2020
medline: 20 1 2021
Statut: ppublish

Résumé

Extracorporeal lung support (ECLS) represents an essential support tool especially for critically ill patients undergoing thoracic surgical procedures. Lung volume reduction surgery (LVRS) is an important treatment option for end-stage lung emphysema in carefully selected patients. Here, we report the efficacy of veno-venous ECLS (VV ECLS) as a bridge to or through LVRS in patients with end-stage lung emphysema and severe hypercapnia. Between January 2016 and May 2017, 125 patients with end-stage lung emphysema undergoing LVRS were prospectively enrolled into this study. Patients with severe hypercapnia caused by chronic respiratory failure were bridged to or through LVRS with low-flow VV ECLS (65 patients, group 1). Patients with preoperative normocapnia served as a control group (60 patients, group 2). In group 1, VV ECLS was implemented preoperatively in five patients and in 60 patients intraoperatively. Extracorporeal lung support was continued postoperatively in all 65 patients. Mean length of postoperative VV ECLS support was 3 ± 1 day. The 90 day mortality rate was 7.8% in group 1 compared with 5% in group 2 (p = 0.5). Postoperatively, a significant improvement was observed in quality of life, exercise capacity, and dyspnea symptoms in both groups. VV ECLS in patients with severe hypercapnia undergoing LVRS is an effective and well-tolerated treatment option. In particular, it increases the intraoperative safety, supports de-escalation of ventilatory strategies, and reduces the rate of postoperative complications in a cohort of patients considered "high risk" for LVRS in the current literature.

Identifiants

pubmed: 32740358
doi: 10.1097/MAT.0000000000001108
pii: 00002480-202008000-00020
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

952-959

Références

Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995.274: 1852–1857.
Vasilyev SS, Chaap RN, Mortensen JD. Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units. Chest 1995.107:1083–1088.
Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest 2001.119: 1840–1849.
Behrendt CE. Acute respiratory failure in the United States: Incidence and 31-day survival. Chest 2000.118: 1100–1105.
Kluge S, Braune SA, Engel M, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med 2012.38: 1632–1639.
Bein T, Weber F, Philipp A, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 2006.34: 1372–1377.
Banfi C, Pozzi M, Siegenthaler N, et al. Veno-venous extracorporeal membrane oxygenation: Cannulation techniques. J Thorac Dis 2016.8: 3762–3773.
Khoshbin E, Roberts N, Harvey C, et al. Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation. ASAIO J 2005.51: 281–287.
Agerstrand CL, Bacchetta MD, Brodie D. ECMO for adult respiratory failure: Current use and evolving applications. ASAIO J 2014.60: 255–262.
Abrams D, Combes A, Brodie D. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 2014.63(25 Pt A): 2769–2778.
Rinieri P, Peillon C, Bessou JP, et al. National review of use of extracorporeal membrane oxygenation as respiratory support in thoracic surgery excluding lung transplantation. Eur J Cardiothorac Surg 2015.47: 87–94.
Redwan B, Semik M, Dickgreber N, Ziegeler S, Fischer S. Single site cannulation veno-venous extracorporeal lung support during pulmonary resection in patients with severely compromised pulmonary function. ASAIO J 2015.61: 366–369.
Redwan B, Ziegeler S, Semik M, et al. Single-site cannulation venovenous extracorporeal CO2 removal as bridge to lung volume reduction surgery in end-stage lung emphysema. ASAIO J 2016.62: 743–746.
Agzarian J, Miller JD, Kosa SD, Malthaner R, Tan L; Canadian Volume Reduction Surgery Study Group: Long-term survival analysis of the Canadian Lung Volume Reduction Surgery trial. Ann Thorac Surg 2013.96: 1217–1222.
Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003.348: 2059–2073.
National Emphysema Treatment Trial Research Group: Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001.345: 1075–1083.
National Emphysema Treatment Trial Research Group: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003.348: 2059–2073.
O’Croinin DF, Nichol AD, Hopkins N, et al. Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury. Crit Care Med 2008.36: 2128–2135.
Masterson C, Otulakowski G, Kavanagh BP. Hypercapnia: Clinical relevance and mechanisms of action. Curr Opin Crit Care 2015.21: 7–12.
O’Croinin D, Ni Chonghaile M, Higgins B, Laffey JG. Bench-to-bedside review: Permissive hypercapnia. Crit Care 2005.9: 51–59.
Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. Am J Respir Crit Care Med 2011.184: 763–770.
Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996.112: 1319–1329; discussion 1329.
Naunheim KS, Wood DE, Mohsenifar Z, et al.; National Emphysema Treatment Trial Research Group: Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006.82: 431–443.
Burki NK, Mani RK, Herth FJF, et al. A novel extracorporeal CO(2) removal system: Results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest 2013.143: 678–686.
Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995.109: 106–116.
Szekely LA, Oelberg DA, Wright C, et al. Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest 1997.111: 550–558.
Wisser W, Klepetko W, Senbaklavaci O, et al. Chronic hypercapnia should not exclude patients from lung volume reduction surgery. Eur J Cardiothorac Surg 1998.14: 107–112.
O’Brien GM, Furukawa S, Kuzma AM, Cordova F, Criner GJ. Improvements in lung function, exercise, and quality of life in hypercapnic COPD patients after lung volume reduction surgery. Chest 1999.115: 75–84.
Argenziano M, Moazami N, Thomashow B, et al. Extended indications for lung volume reduction surgery in advanced emphysema. Ann Thorac Surg 1996.62: 1588–1597.
McKenna RJ Jr, Brenner M, Fischel RJ, et al. Patient selection criteria for lung volume reduction surgery. J Thorac Cardiovasc Surg 1997.114: 957–964; discussion 964.
Ciccone AM, Meyers BF, Guthrie TJ, et al. Long-term outcome of bilateral lung volume reduction in 250 consecutive patients with emphysema. J Thorac Cardiovasc Surg 2003.125: 513–525.
Fischer S, Hoeper MM, Tomaszek S, et al. Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: The initial Hannover experience. ASAIO J 2007.53: 168–170.
Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg 2006.131: 719–723.
Olsson KM, Simon A, Strueber M, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010.10: 2173–2178.
Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012.185: 763–768.
Redwan B, Ziegeler S, Dickgreber N, Fischer S. Metastasectomy in a lung graft using high-flow venovenous extracorporeal lung support in a patient after single lung transplantation. J Thorac Cardiovasc Surg 2015.150: e79–e81.

Auteurs

Ali Akil (A)

From the Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Stephan Ziegeler (S)

Department of Anesthesiology, Intensive Care Medicine and Pain Management, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Jan Reichelt (J)

From the Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Mahyar Lavae-Mokhtari (M)

Department of Respiratory Medicine, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Stefan Freermann (S)

From the Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Michael Semik (M)

From the Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Joachim Fichter (J)

Department of Respiratory Medicine, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Stephanie Rehers (S)

Department of Anesthesiology, Intensive Care Medicine and Pain Management, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Nicolas Johannes Dickgreber (NJ)

Department of Respiratory Medicine, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Lars Richter (L)

From the Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Erik Christian Ernst (EC)

Department of Respiratory Medicine and Pulmonary Rehabilitation, Karl-Hansen-Hospital, Bad Lippspringe, Germany.

Stefan Fischer (S)

From the Department of Thoracic Surgery and Lung Support, Ibbenbueren General Hospital, Ibbenbueren, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH